Explore more publications!

Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

Press releases published on February 4, 2026

Max Force Power Male Enhancement Gummies Product Information Updated as Consumer Interest in Male Vitality Supplement Options Grows in 2026
Novarad to Attend 2026 Society of Interventional Oncology Annual Scientific Meeting in Savannah, Georgia
Manifest and Kapnick Insurance Partner to Improve Healthcare Options for Michigan Employers
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
MEN Balance Pro Consumer Report (2026): Public Product Information and Evaluation Factors (Not a Review)
His Choice Health Launches Unified Men’s Health Brand After 10,000+ Vasectomy Procedures
Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
Olema Oncology to Participate in Upcoming Investor Conferences
STERIS Announces Financial Results for Fiscal 2026 Third Quarter
Banner Health names new senior vice president of finance
The Ensign Group Reports Fiscal Year and Fourth Quarter 2025 Results; Issues 2026 Annual Earnings and Revenue Guidance
Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ascendis Pharma to Report Full Year 2025 Financial Results and Provide Business Update on February 11, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions